Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome

World Journal of Gastroenterology

Volumn 17, Issue 44, 2011, Pages 4911-4916

  Deng, Zhi Gang ^a   Zhou, Jian Yin ^a   Yin, Zhen Yu ^a   Peng, You Yuan ^a   Wang, Fu Qiang ^a   Wang, Xiao Min ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Abdominal compartment syndrome; Arterial infusion; Laparotomy; Severe acute pancreatitis

Indexed keywords

ANTIBIOTIC AGENT; OCTREOTIDE; PROTEINASE INHIBITOR;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL PRESSURE; ACUTE PANCREATITIS; ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DECOMPRESSION SURGERY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; FEMALE; GASTROEPIPLOIC ARTERY; HUMAN; INTRAABDOMINAL HYPERTENSION; LAPAROTOMY; MALE; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

EID: 83155165460     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i44.4911     Document Type: Article

References (28)

1. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590
2. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004; 53: 1340-1344
3. Gecelter G, Fahoum B, Gardezi S, Schein M. Abdominal compartment syndrome in severe acute pancreatitis: an indication for a decompressing laparotomy? Dig Surg 2002; 19: 402-404; discussion 402-404
4. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D'Amours S, Wendon J, Hillman K, Wilmer A. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 2007; 33: 951-962
5. Takeda K, Matsuno S, Ogawa M, Watanabe S, Atomi Y. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg 2001; 8: 216-220
6. Ino Y, Arita Y, Akashi T, Kimura T, Igarashi H, Oono T, Furukawa M, Kawabe K, Ogoshi K, Ouchi J, Miyahara T, Takayanagi R, Ito T. Continuous regional arterial infusion therapy with gabexate mesilate for severe acute pancreatitis. World J Gastroenterol 2008; 14: 6382-6387
7. Nakagawa M, Ogino H, Shimohira M, Hara M, Shibamoto Y. Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child. Cardiovasc Intervent Radiol 2009; 32: 581-584
8. Takeda K. Antiproteases in the treatment of acute necrotizing pancreatitis: continuous regional arterial infusion. JOP 2007; 8: 526-532
9. Mikami Y, Takeda K, Omura N, Abe H, Fukuyama S, Motoi F, Egawa S, Sunamura M, Matsuno S. New strategy for acute necrotizing pancreatitis: Continuous Regional Arterial Infusion (CRAI) therapy. Rocz Akad Med Bialymst 2005; 50: 101-105
10. Imaizumi H, Kida M, Nishimaki H, Okuno J, Kataoka Y, Kida Y, Soma K, Saigenji K. Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit. Pancreas 2004; 28: 369-373
11. Takeda K, Sunamura M, Shibuya K, Kobari M, Matsuno S. Role of early continuous regional arterial infusion of protease inhibitor and antibiotic in nonsurgical treatment of acute necrotizing pancreatitis. Digestion 1999; 60 Suppl 1: 9-13
12. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-336
13. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201-205
14. Malfertheiner P, Domínguez-Muñoz JE. Prognostic factors in acute pancreatitis. Int J Pancreatol 1993; 14: 1-8
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829
16. Wilson C, Imrie CW. Current concepts in the management of pancreatitis. Drugs 1991; 41: 358-366
17. Scheppach W. Abdominal compartment syndrome. Best Pract Res Clin Gastroenterol 2009; 23: 25-33
18. Valderrama R, Pérez-Mateo M, Navarro S, Vázquez N, Sanjosé L, Adrián MJ, Estruch J. Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis. Digestion 1992; 51: 65-70
19. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999; 25: 195-210
20. Satoh H, Harada M, Tashiro S, Shiroya T, Imawaka H, Machii K. The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis. J Med Invest 2004; 51: 186-193
21. Mikami Y, Takeda K, Matsuda K, Qiu-Feng H, Fukuyama S, Egawa S, Sunamura M, Matsuno S. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas 2005; 30: 248-253
22. Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176: 480-483
23. Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 2001; 22: 28-31
24. Hartwig W, Werner J, Uhl W, Büchler MW. Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 423-428
25. Güler O, Akturan S, Kisli E, Dolapçi I, Caydere M, Akova A. Acute pancreatitis, bacterial translocation, and different octreotide regimens: an experimental study. Surg Today 2009; 39: 876-883
26. Uhl W, Büchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999; 45: 97-104
27. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan O, Skornik Y, Freund U. Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 2000; 45: 2247-2251
28. Wenger FA, Kilian M, Heukamp I, Foitzik T, Jacobi CA, Guski H, Schimke I, Müller JM. Effects of octreotide in acute hemorrhagic necrotizing pancreatitis in rats. J Gastroenterol Hepatol 2007; 22: 1872-1876